Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft-Reference-Cited by-同舟云学术

Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft

Published:2020-10-21 Issue:2 Volume:19 Page:346-357
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Morton J. Jason,Alzofon Nathaniel,Keysar Stephen B.^ORCID,Chimed Tugs-Saikhan,Reisinger Julie^ORCID,Perrenoud Loni,Le Phuong N.,Nieto Cera,Gomez Karina,Miller Bettina,Yeager Randi,Gao Dexiang,Tan Aik-Choon,Somerset Hilary,Medina Theresa,Wang Xiao-Jing^ORCID,Wang Jing H.^ORCID,Robinson William,Roop Dennis R.^ORCID,Gonzalez Rene,Jimeno Antonio

Funder

NIH

University of Colorado Cancer Center

University of Colorado Skin Diseases Research Center

Ruth L. Kirschstein National Research Service

Training in Otolaryngology Research

American Cancer Society

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma;JNCI: Journal of the National Cancer Institute;2023-06-30

2. Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice;Cancers;2023-05-30

3. Autologous CD34+ stem cell humanization in head and neck cancer modeling: The translational importance of T cell maturation;Oral Oncology Reports;2023-03

4. Humanized mouse models for immuno-oncology research;Nature Reviews Clinical Oncology;2023-01-12

5. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval;Cells;2021-11-09